Burry’s last big play was against Nvidia and Palantir – an options bet with a notional value of $1.1 billion. He compared the high-flying AI stocks to the dot-com bubble of 2000. Today, as then, Burry ...
The cryptocurrency sector, famed for its volatility, has continued to boom during 2025, alongside the second Trump administration’s embrace of the technology. Bitcoin is trading at over $100,000 USD, ...
At the Securities and Exchange Commission, the inbox has been filling up with hundreds of near-identical Freedom of Information Act requests about a little-known company called Meta Materials, Inc., ...
It’s the end of an era in the pharmacy world – as of this week, Rite-Aid has closed all of its stores, leaving its competitors CVS and Walgreens as the remaining standalone pharmacy chains. The ...
Roblox’s Apple Store listing promises the “ultimate virtual universe that lets you create, share experiences with friends, and be anything you can imagine.” The video game platform plays host to ...
On April 14, 2021, online forums where retail investors and short sellers exchange research, rumors, and trading strategies were buzzing. On Reddit and Twitter, meme stock traders were watching for ...
As the Trump Administration’s tariff pause is set to expire next week, SunCoke Energy, Inc. (NYSE: SXC) announced plans to acquire Phoenix Global, a privately held provider of mill services to steel ...
As malls across America struggle for shoppers, DICK’S Sporting Goods, Inc. announced plans to acquire Foot Locker, Inc. for $2.5 billion. The merger agreement permits Foot Locker shareholders to elect ...
Short seller Christian Lamarco likes to court controversy. When he founded his New York firm in 2019, he named it Culper Research – after the Culper Spy Ring, which operated during the American ...
Alternative asset management firm TPG announced plans to acquire Sabre Corporation’s Hospitality Solutions business for $1.1 billion. The all-cash deal is projected to net Sabre $960 million, after ...
Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a ...
The revolving door between the Food and Drug Administration and the pharmaceutical industry took another fast spin when Pfizer announced that Patrizia Cavazzoni would be returning to the company as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback